Trial Profile
Compound Edaravone Injection for Acute Ischemic Stroke, a Multi-center, Randomized, Double-blind, Multi-dose, Parallel, and Controlled Phase II Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Borneol/edaravone (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Sponsors Jiangsu Simcere Pharmaceutical
- 23 Mar 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 22 Apr 2014 New trial record